4DMedical Limited
FDMDFOTCHealthcare● Active
$2.66
+$0.00(+0.00%)
Market Cap$1.6B
P/E Ratio—
52W High$5
52W Low$0.16245
4DMedical Limited (FDMDF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FDMDF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 26, 2026EPS Actual
-$0.17
Est. -$0.02 · -615.6%
Revenue
$0.00B
Est. $0.00B · -4.9%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 26, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
FDMDF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 27, 2026 | -$0.03 | — | — | — | $0.01B | — |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.02 | -$0.17 | -615.6% | $0.00B | $0.00B | -4.9% |
| — Q3 FY2025 | Aug 28, 2025 | — | -$0.03 | — | $0.00B | $0.00B | -28.1% |
| ▲ Q1 FY2025 | Feb 26, 2025 | -$0.02 | -$0.02 | +22.5% | $0.00B | $0.00B | -23.8% |
| — Q3 FY2024 | Sep 29, 2024 | — | -$0.05 | — | $0.00B | $0.00B | -47.1% |
| — Q2 FY2024 | May 10, 2024 | — | -$0.03 | — | $0.00B | $0.00B | -60.4% |
| — Q2 FY2023 | Jun 30, 2023 | — | -$0.03 | — | $0.00B | $0.00B | -82.2% |
| — Q1 FY2023 | Feb 27, 2023 | — | -$0.04 | — | $0.00B | — | — |
Q3 FY2026
Aug 27, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.17
EPS Est.
-$0.02
EPS Surpr.
-615.6%
Revenue
$0.00B
Q3 FY2025
Aug 28, 2025
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
+22.5%
Revenue
$0.00B
Q3 FY2024
Sep 29, 2024
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 10, 2024
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Feb 27, 2023
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 26, 2026 | -615.6% | $2.19 | $2.19 | +0.00% |
| — Q3 FY2025 | Aug 28, 2025 | — | $0.33 | $0.33 | +0.00% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +22.5% | $0.34 | $0.34 | +0.00% |
| — Q3 FY2024 | Sep 29, 2024 | — | $0.32 | $0.32 | +0.00% |
| — Q2 FY2024 | May 10, 2024 | — | $0.45 | $0.41 | -8.27% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.63 | $0.53 | -16.42% |
| — Q1 FY2023 | Feb 27, 2023 | — | $0.22 | $0.22 | +0.00% |
| — Q3 FY2022 | Aug 18, 2022 | — | $0.37 | $0.37 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 26, 2026
EPS Beat/Miss
-615.6%
Price Before
$2.19
Price After
$2.19
Q3 FY2025+0.00%
Report Date
Aug 28, 2025
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.33
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
+22.5%
Price Before
$0.34
Price After
$0.34
Q3 FY2024+0.00%
Report Date
Sep 29, 2024
EPS Beat/Miss
—
Price Before
$0.32
Price After
$0.32
Q2 FY2024-8.27%
Report Date
May 10, 2024
EPS Beat/Miss
—
Price Before
$0.45
Price After
$0.41
Q2 FY2023-16.42%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.63
Price After
$0.53
Q1 FY2023+0.00%
Report Date
Feb 27, 2023
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.22
Q3 FY2022+0.00%
Report Date
Aug 18, 2022
EPS Beat/Miss
—
Price Before
$0.37
Price After
$0.37
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move-16.42% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FDMDF ends December
4DMedical Limited (FDMDF) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $-0.17 — missing the analyst consensus of $-0.02 by -615.6%. The next FDMDF earnings date is expected around September 1, 2026.
Each quarter, investors track FDMDF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FDMDF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FDMDF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FDMDF earnings · 5 questions4DMedical Limited's next earnings report is expected around September 1, 2026. FDMDF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FDMDF historically reports after market close (AMC).
FDMDF earnings datewhen is FDMDF earningsFDMDF next earnings datewhen does FDMDF report earningsFDMDF earnings calendar
▸ Source: FMP · 4DMedical Limited SEC filings · US GAAP · 4DMedical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026